Specify a stock or a cryptocurrency in the search bar to get a summary
Embecta Corp
EMBCEmbecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey. Address: 300 Kimball Drive, Parsippany, NJ, United States, 07054
Analytics
WallStreet Target Price
16.07 USDP/E ratio
12.95Dividend Yield
4.1 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures EMBC
Dividend Analytics EMBC
Dividend growth over 5 years
–Continuous growth
1 yearPayout Ratio 5 years average
28 %Dividend History EMBC
Stock Valuation EMBC
Financials EMBC
Results | 2019 | Dynamics |